Given APOE’s role in AD risk, a better understanding of its relationships with T2DM and CVD may clarify the contribution of cardiometabolic health to dementia risk and provide insights into prevention and treatment approaches. The gene discussed is APOE; the disease is type 2 diabetes mellitus.